Indivior to Participate in the Stifel 2025 Healthcare Conference

About this update from Stifel Financial Corporation

RICHMOND, Va. , Oct. 28, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Stifel 2025 Healthcare Conference: About Indivior Indivior Pharmaceuticals works to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a human crisis to a recognized and treated chronic disease. Building on its portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Visit  www.indivior.com  to learn more. Connect with Indivior on LinkedIn by visiting  www.linkedin.com/company/Indivior. View original content to download multimedia: https://www.prnewswire.com/news-releases/indivior-to-participate-in-the-stifel-2025-healthcare-conference-302596900.html

View stock analysis, news, and events for Stifel Financial Corporation